Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in ...

To add to the relevance of this point, not only are HCPs expecting them, but we know that they work. In fact, as IQVIA’s ChannelDynamics shows, the impact of remote detailing on HCPs reported ...

The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Despite more treatment options being a positive, Ben ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...